Androgen Deprivation Therapy and the Risk of Coronary Heart Disease and Heart Failure in Patients with Prostate Cancer

Androgen-Deprivation Therapy in Prostate Cancer and Cardiovascular Risk

(2010) Glenn N. Levine et al.   CIRCULATION

Absolute and Relative Risk of Cardiovascular Disease in Men With Prostate Cancer: Results From the Population-Based PCBaSe Sweden

(2010) Mieke Van Hemelrijck et al.   JOURNAL OF CLINICAL ONCOLOGY

External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study

(2010) Michel Bolla et al.   LANCET ONCOLOGY

Testosterone deficiency: a risk factor for cardiovascular disease?

(2010) T.H. Jones   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Validation and validity of diagnoses in the General Practice Research Database: a systematic review

(2009) Emily Herrett et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Impact of Androgen Deprivation Therapy on Cardiovascular Disease and Diabetes

(2009) Shabbir M.H. Alibhai et al.   JOURNAL OF CLINICAL ONCOLOGY

Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy: Observational Study of Veterans With Prostate Cancer

(2009) N. L. Keating et al.   JNCI-Journal of the National Cancer Institute

Population-based cancer survival trends in England and Wales up to 2007: an assessment of the NHS cancer plan for England

(2009) Bernard Rachet et al.   LANCET ONCOLOGY

Causes of death in men undergoing androgen suppression therapy for newly diagnosed localized or recurrent prostate cancer

(2008) Anthony V. D'Amico et al.   CANCER

Androgen deprivation therapy for prostate cancer

(2008) Eric A Singer et al.   EXPERT OPINION ON PHARMACOTHERAPY

Cardiovascular Mortality After Androgen Deprivation Therapy for Locally Advanced Prostate Cancer: RTOG 85-31

(2008) Jason A. Efstathiou et al.   JOURNAL OF CLINICAL ONCOLOGY